Early Psychosis Care Was Followed by Sharp Drops in Suicidal Thoughts and Attempts
A 2026 analysis of nearly 3,000 people in U.S. early-psychosis clinics found substantially lower odds of suicidal thoughts and attempts over two…
Clozapine, Paliperidone and Olanzapine Show the Largest Estimated Reductions in Hostility—but No Clear Winner
A 2026 analysis found that several antipsychotics reduced hostility and aggression ratings compared with placebo. However, the evidence was rated low or…
NF1 Meta-Analysis Finds ADHD Common, but Estimates Vary Widely
A 2026 review estimated ADHD in 33% of people with neurofibromatosis type 1, while emphasizing wide differences between studies and the limits…
A personalised approach may help people stay on antidepressants in the first weeks of treatment
The PETRUSHKA digital tool combines prediction models with patient preferences about side effects. In a randomised trial, people using it were less…
Virtual Reality Improved Some Memory Tests in Alzheimer’s Trials, but Not Daily Function
A 2026 review found modest gains in cognitive test scores after short VR training programs for people with Alzheimer’s dementia. It found…
Nature Mental Health Corrects Reported Brain-Structure Estimates in Income-Inequality Study
Nature Mental Health has updated a study on macroeconomic income inequality, brain structure and mental health after correcting three reported statistical estimates…
Eli Lilly’s Vogue World sponsorship raises questions about fashion, health and body image
Eating disorder advocates and academics have criticized Eli Lilly’s role as a Vogue World sponsor, saying the partnership may blur the line…
Celecoxib’s Possible Add-On Benefit for Depression Remains Uncertain
A 2026 review of seven randomized trials found a possible improvement when celecoxib was added to antidepressants, but inconsistent results, study-quality concerns…
Cannabis Policy May Shape Mental-Health Risk Through Availability and THC Strength
Two 2026 evidence reviews suggest that commercialised cannabis markets, frequent use and high-THC products deserve closer attention—particularly in relation to psychosis.
NHS Areas Set Minimum Waits of Up to Two Years for ADHD and Autism Assessments
Four NHS integrated care boards in England have introduced minimum waits of at least two years for some ADHD and autism assessments,…